Fig. 2
Changes in glycemic control markers (mean ± SD) in the treatment and control groups at different time points across FPG (mmol/L), FI (µIU/mL), 2 h-OGTT (mmol/L), HbA1c (%), and HOMA-IR (units). FPG: Fasting Plasma Glucose; FI: Fasting Insulin; 2 h-OGTT: 2-hour Oral Glucose Tolerance Test; HBA1c: Hemoglobin A1c; HOMA-IR: homeostatic model assessment-insulin resistance. Error bars indicate one standard deviation from the mean. *ANOVA p < 10 − 5 versus control